BRPI1007295A - peptídeos antibióticos - Google Patents
peptídeos antibióticosInfo
- Publication number
- BRPI1007295A BRPI1007295A BRPI1007295A BRPI1007295A BR PI1007295 A BRPI1007295 A BR PI1007295A BR PI1007295 A BRPI1007295 A BR PI1007295A BR PI1007295 A BRPI1007295 A BR PI1007295A
- Authority
- BR
- Brazil
- Prior art keywords
- antibiotic peptides
- antibiotic
- peptides
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
- A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
- A01N47/44—Guanidine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102009007381A DE102009007381A1 (de) | 2009-01-29 | 2009-01-29 | Antibiotische Peptide |
| PCT/EP2010/051072 WO2010086401A1 (de) | 2009-01-29 | 2010-01-29 | Antibiotische peptide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI1007295A true BRPI1007295A (pt) | 2016-02-02 |
| BRPI1007295A8 BRPI1007295A8 (pt) | 2016-08-09 |
Family
ID=42124600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1007295A BRPI1007295A8 (pt) | 2009-01-29 | 2010-01-29 | peptídeos antibióticos |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US8686113B2 (pt) |
| EP (1) | EP2391636B1 (pt) |
| JP (1) | JP2012516142A (pt) |
| KR (1) | KR20110120917A (pt) |
| CN (1) | CN102369210A (pt) |
| AU (1) | AU2010209695A1 (pt) |
| BR (1) | BRPI1007295A8 (pt) |
| CA (1) | CA2751010A1 (pt) |
| DE (1) | DE102009007381A1 (pt) |
| IL (1) | IL214365A0 (pt) |
| MX (1) | MX2011008030A (pt) |
| RU (1) | RU2011135755A (pt) |
| WO (1) | WO2010086401A1 (pt) |
| ZA (1) | ZA201105852B (pt) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8937155B2 (en) | 2010-05-28 | 2015-01-20 | Amp Therapeutics Gmbh | Antimicrobial peptides and peptide derivatives derived from Oncopeltus fasciatus |
| DE102011118029A1 (de) | 2011-06-20 | 2012-12-20 | Universität Leipzig | Modifizierte antibiotische Peptide mit variabler systemischer Freisetzung |
| CN102276691B (zh) * | 2011-08-04 | 2013-03-13 | 东北农业大学 | 一种抗菌肽及其制备方法 |
| BR112014003340B1 (pt) * | 2011-08-12 | 2021-05-18 | Atlantic Industries Limited | chapa de metal corrugada e estrutura elevada incorporando a mesma |
| WO2013041663A2 (de) * | 2011-09-22 | 2013-03-28 | Amp-Therapeutics Gmbh | Modifizierte apidaecinderivate als antibiotische peptide |
| WO2013064633A1 (de) | 2011-11-04 | 2013-05-10 | Amp-Therapeutics Gmbh | Oncopeltus-peptidderivate als antimikrobielle peptide |
| US20130325121A1 (en) * | 2012-05-31 | 2013-12-05 | Clemson University | Protein based materials, plastic albumin devices and related methods |
| WO2014039013A1 (en) * | 2012-09-07 | 2014-03-13 | Agency Of Science, Technology And Research | Tetrabranched peptides and analogues as a new class of antimicrobials and their preparation thereof |
| US9273093B2 (en) * | 2012-10-11 | 2016-03-01 | Protagonist Therapeutics, Inc. | α4β7 peptide dimer antagonists |
| KR20140088837A (ko) * | 2013-01-03 | 2014-07-11 | 한미약품 주식회사 | N-말단 전하가 변형된 인슐린 분비 펩티드 유도체 |
| HK1217898A1 (zh) * | 2013-02-22 | 2017-01-27 | 纽约市哥伦比亚大学理事会 | 通過抑制轉錄因子atf5來抑制腫瘤細胞的組合物和方法 |
| RS62633B1 (sr) | 2013-03-15 | 2021-12-31 | Protagonist Therapeutics Inc | Analozi hepcidina i njihove primene |
| FR3005963B1 (fr) * | 2013-05-24 | 2016-02-26 | Centre Nat Rech Scient | Bacterie isolee du genre pseudoalteromonas, cyclolipopeptides, et leurs utilisations |
| US10266566B2 (en) | 2013-07-15 | 2019-04-23 | North Carolina State University | Protease-resistant peptide ligands |
| SI3143037T1 (sl) | 2014-05-16 | 2021-11-30 | Protagonist Therapeutics, Inc. | Antagonisti integrin alpha4beta7 tioeterskih peptidov |
| CN107206254B (zh) | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| US9029319B1 (en) * | 2014-08-04 | 2015-05-12 | Centaur, Inc. | Water buffalo derived peptide antibiotic therapies |
| WO2016054411A1 (en) | 2014-10-01 | 2016-04-07 | Protagonist Therapeutics, Inc. | NOVEL α4β7 PEPTIDE MONOMER AND DIMER ANTAGONISTS |
| WO2016054445A1 (en) | 2014-10-01 | 2016-04-07 | Protagonist Therapeutics, Inc. | Novel cyclic monomer and dimer peptides having integrin antagonist activity |
| RU2566554C1 (ru) * | 2015-01-12 | 2015-10-27 | Федеральное бюджетное учреждение науки "Ростовский научно-исследовательский институт микробиологии и паразитологии" (ФБУН РостовНИИ микробиологии и паразитологии) | ШТАММ Stenotrophomonas maltophilia, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ АНТИГЕНА ДЛЯ ОПРЕДЕЛЕНИЯ АНТИТЕЛ К Stenotrophomonas maltophilia В БИОЛОГИЧЕСКИХ СРЕДАХ |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| CA3009834A1 (en) | 2015-12-30 | 2017-07-06 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| WO2017165676A1 (en) | 2016-03-23 | 2017-09-28 | Protagonist Therapeutics, Inc. | METHODS FOR SYNTHESIZING α4β7 PEPTIDE ANTAGONISTS |
| CN113521007B (zh) * | 2016-07-01 | 2022-11-18 | 四川大学 | 抗菌肽衍生物在制备免疫佐剂中的用途 |
| EP4092038A1 (en) | 2017-09-11 | 2022-11-23 | Protagonist Therapeutics, Inc. | Opioid agonist peptides and uses thereof |
| EP4501952A3 (en) | 2018-02-08 | 2025-04-16 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| EP3820883A4 (en) | 2018-07-12 | 2022-04-20 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| CN108864270B (zh) * | 2018-07-19 | 2021-03-30 | 四川理工学院 | 一种白蚁抗菌肽及其应用 |
| CN116082455A (zh) | 2019-07-10 | 2023-05-09 | 领导医疗有限公司 | 白细胞介素-23受体的肽抑制剂及其用于治疗炎症性疾病的用途 |
| EP4090669A4 (en) | 2020-01-15 | 2024-11-20 | Janssen Biotech, Inc. | PEPTIDE INHIBITORS OF THE INTERLEUKIN-23 RECEPTOR AND THEIR USE IN TREATING INFLAMMATORY DISEASES |
| SI4090670T1 (sl) | 2020-01-15 | 2025-08-29 | Janssen Biotech, Inc. | Peptidni zaviralci receptorja interlevkina-23 in njihova uporaba za zdravljenje vnetnih bolezni |
| IL316550A (en) | 2020-11-20 | 2024-12-01 | Janssen Pharmaceutica Nv | Compositions of interleukin-23 receptor peptide inhibitors |
| CA3173504A1 (en) * | 2020-12-15 | 2022-06-23 | Dietrich A. Stephan | Oligonucleotide analogue therapeutics for treatment of neuromuscular disease |
| CN113549137B (zh) * | 2021-07-09 | 2022-04-19 | 东北农业大学 | 一种靶向革兰氏阴性菌的富脯氨酸抗菌肽Pyr-2及其制备方法与应用 |
| IL310061A (en) | 2021-07-14 | 2024-03-01 | Janssen Biotech Inc | Peptide inhibitors linked to fatty residues of the interleukin-23 receptor |
| CN116789740B (zh) * | 2023-06-25 | 2025-04-01 | 黑龙江八一农垦大学 | 一种细胞穿透肽、入胞抗菌肽及其应用 |
| CN118047841B (zh) * | 2024-04-09 | 2024-06-11 | 中国农业科学院农业基因组研究所 | 一种发酵桑叶抗菌肽Squ8及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028A (en) * | 1847-03-20 | monohot | ||
| EP0299828B1 (en) | 1987-07-01 | 1994-06-15 | Plant Genetic Systems N.V. | Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications |
| US5466671A (en) | 1994-03-02 | 1995-11-14 | Sloan-Kettering Institute For Cancer Research | Apidaecin-type peptide antibiotics with improved activities and/or different antibacterial spectrum |
| WO2000078956A1 (en) | 1999-06-23 | 2000-12-28 | The Wistar Institute Of Anatomy And Biology | Novel pyrrhocoricin-derived peptides, and methods of use thereof |
| US20030104622A1 (en) * | 1999-09-01 | 2003-06-05 | Robbins Paul D. | Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses |
| US20020041898A1 (en) | 2000-01-05 | 2002-04-11 | Unger Evan C. | Novel targeted delivery systems for bioactive agents |
| WO2002079467A2 (en) * | 2001-03-29 | 2002-10-10 | Københavns Universitet | Antibiotic-free bacterial strain selection with antisense molecules |
| AU2003216091A1 (en) | 2002-01-22 | 2003-09-02 | Intrabiotics Pharmaceuticals, Inc. | Hybrid synthetic method for antimicrobial peptides |
| WO2003079997A2 (en) * | 2002-03-21 | 2003-10-02 | Cayman Chemical Company | Prostaglandin f2 alpha analogs in combinaiotn with antimicrobials for treating glaucoma |
| US20050058603A1 (en) | 2003-05-02 | 2005-03-17 | Case Western Reserve University | Drug delivery system based on polymer nanoshells |
| WO2005090385A2 (en) * | 2004-03-18 | 2005-09-29 | Ansata Therapeutics, Inc. | Compositions having antimicrobial activity and uses thereof |
| DE102007036128A1 (de) | 2007-07-23 | 2009-02-12 | Universität Leipzig | Antibiotische Peptide |
-
2009
- 2009-01-29 DE DE102009007381A patent/DE102009007381A1/de not_active Withdrawn
-
2010
- 2010-01-29 EP EP10705318.3A patent/EP2391636B1/de not_active Not-in-force
- 2010-01-29 RU RU2011135755/04A patent/RU2011135755A/ru not_active Application Discontinuation
- 2010-01-29 US US13/147,095 patent/US8686113B2/en active Active
- 2010-01-29 CN CN2010800158123A patent/CN102369210A/zh active Pending
- 2010-01-29 CA CA2751010A patent/CA2751010A1/en not_active Abandoned
- 2010-01-29 MX MX2011008030A patent/MX2011008030A/es unknown
- 2010-01-29 BR BRPI1007295A patent/BRPI1007295A8/pt not_active IP Right Cessation
- 2010-01-29 KR KR1020117019813A patent/KR20110120917A/ko not_active Withdrawn
- 2010-01-29 WO PCT/EP2010/051072 patent/WO2010086401A1/de not_active Ceased
- 2010-01-29 AU AU2010209695A patent/AU2010209695A1/en not_active Abandoned
- 2010-01-29 JP JP2011546854A patent/JP2012516142A/ja active Pending
-
2011
- 2011-07-31 IL IL214365A patent/IL214365A0/en unknown
- 2011-08-10 ZA ZA2011/05852A patent/ZA201105852B/en unknown
-
2014
- 2014-02-25 US US14/188,913 patent/US20150299256A1/en not_active Abandoned
-
2016
- 2016-08-04 US US15/228,116 patent/US20170114096A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2751010A1 (en) | 2010-08-05 |
| RU2011135755A (ru) | 2013-03-10 |
| ZA201105852B (en) | 2013-03-27 |
| US20150299256A1 (en) | 2015-10-22 |
| EP2391636A1 (de) | 2011-12-07 |
| US20170114096A1 (en) | 2017-04-27 |
| DE102009007381A1 (de) | 2010-08-05 |
| MX2011008030A (es) | 2011-09-27 |
| AU2010209695A1 (en) | 2011-09-15 |
| BRPI1007295A8 (pt) | 2016-08-09 |
| US20120021975A1 (en) | 2012-01-26 |
| JP2012516142A (ja) | 2012-07-19 |
| IL214365A0 (en) | 2011-09-27 |
| WO2010086401A1 (de) | 2010-08-05 |
| US8686113B2 (en) | 2014-04-01 |
| KR20110120917A (ko) | 2011-11-04 |
| EP2391636B1 (de) | 2017-09-27 |
| CN102369210A (zh) | 2012-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1007295A (pt) | peptídeos antibióticos | |
| BRPI0814587A2 (pt) | Peptídeos antibióticos | |
| PT2406399T (pt) | Proteínas mirac | |
| EP2497655A4 (en) | TIRES | |
| BRPI1013989A2 (pt) | pneumático | |
| DK2462134T3 (da) | N1-sulfonyl-5-fluorpyrimidinonderivater | |
| BRPI1011967A2 (pt) | pneumático | |
| DE112010002949A5 (de) | Kupplungstastpunkte | |
| PT2464370T (pt) | Péptidos vasoativos intestinais modificados | |
| BRPI1008827A2 (pt) | deisobutenizador | |
| BRPI1014968A2 (pt) | subalargador | |
| EP2437770A4 (en) | ANTIMICROBIAL PEPTIDES | |
| DE112010002728A5 (de) | Turboinhalator | |
| BRPI1013720A2 (pt) | pneumático | |
| EP2289713A4 (en) | TIRE | |
| DE112009005323A5 (de) | Hebelarmprüfmaschine | |
| BRPI1010661A2 (pt) | peptídeo | |
| BRPI1007884A2 (pt) | derivados de actagardina | |
| DE112009005462T8 (de) | Lenkungsssteuervorrichtung | |
| BRPI1008070A2 (pt) | tricianoboratos | |
| BR112012004964A2 (pt) | girocóptero | |
| BRPI1008662A2 (pt) | pneumático | |
| EP2418102A4 (en) | TIRE | |
| FR2947857B1 (fr) | Agencement de deshuileur | |
| BRPI1007486A2 (pt) | pneumático |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B25E | Requested change of name of applicant rejected |
Owner name: AMP-THERAPEUTICS GMBH AND CO. KG (DE) |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: C07K 7/08 (2006.01), A01N 47/44 (2006.01), A61K 38 |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |